Revelation Biosciences's chart data is dated 2026-10-07. Recorded technical signals: RSI rebound, Mean reversion. There are 0 published signal records.
Revelation Biosciences last closed at $0.8281 (+10.09%) on 2026-10-07. Signals today: RSI rebound, Mean reversion. Listed on Nasdaq. Trailing 12 months PER is -0.3×. Its overall grade ranks 650 of 737 stocks in Healthcare.
About this company
Revelation Biosciences last closed at $0.8281 (+10.09%) on 2026-10-07. Signals today: RSI rebound, Mean reversion. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall D · 650/737
Valuation grade C+
Related stocks
- RocheCompetitor
Revelation Biosciences와 같은 면역·염증/진단 계열 바이오 영역에서 비교되는 글로벌 대형 제약·진단사
- MerckCompetitor
면역·염증 및 감염질환 치료제 개발 경쟁에서 비교 대상이 되는 대형 제약사
- Johnson & JohnsonCompetitor
면역·염증 및 제약 파이프라인 측면에서 경쟁하는 글로벌 헬스케어 대기업
About Revelation Biosciences
- What technical signals does Revelation Biosciences (REVB) have?
- Revelation Biosciences current technical signals: RSI rebound, Mean reversion.
- Is Revelation Biosciences a cup-and-handle pattern?
- No. Revelation Biosciences has no valid Cup signal right now.
- What published figures are available for Revelation Biosciences?
- Market cap: $1.23M. Trailing 12 months PER: -0.3×. Latest quarter PBR: 0.31×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Turn what you saw on this name into a strategy
Ask Q about Revelation Biosciences, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.